Connor, Clark & Lunn Investment Management Ltd.
Position in JNJ — Johnson & Johnson
CIK 1596800
VANCOUVER, A1
Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$78,076,219
+$8,109,181 QoQ
Shares Held
307,423
+7.4% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#352
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $830,990,729 across 11 Drug Manufacturers - General names. JNJ ranks #6 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
173,392 | $207,971,583 | |
| 2 | ABBV |
AbbVie Inc.
|
751,485 | $189,103,685 | |
| 3 | GSK |
GSK plc
|
2,767,591 | $145,077,119 | |
| 4 | NVS |
Novartis AG
|
740,532 | $116,056,174 | |
| 5 | SNY |
Sanofi
|
1,835,859 | $78,317,744 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
307,423 | $78,076,219 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
46,429 | $5,865,839 | |
| 8 | MRK |
Merck & Co., Inc.
|
38,087 | $4,894,179 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,076,219 | 307,423 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $69,967,038 | 286,234 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $21,399,664 | 103,405 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $35,227,945 | 189,990 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $26,568,724 | 173,936 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $19,776,917 | 119,253 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $54,353,113 | 375,834 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $9,268,535 | 57,192 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $75,647,300 | 517,565 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $86,743,328 | 548,349 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,675,089 | 61,727 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $50,397,740 | 323,581 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $41,438,263 | 250,352 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $109,528,270 | 706,634 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $150,663,548 | 852,893 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $35,842,327 | 219,407 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $46,170,173 | 260,099 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $62,524,440 | 352,787 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $78,128,866 | 456,707 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $114,894,976 | 711,424 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $122,420,929 | 743,116 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $127,552,363 | 776,102 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $128,757,299 | 818,130 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $83,473,294 | 560,675 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $61,799,572 | 439,448 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $27,829,851 | 212,231 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||